HbO2 Therapeutics Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
IPO
- (Cancelled)
- Latest Deal Amount
-
$30M
HbO2 Therapeutics General Information
Description
Developer of human and veterinary hemoglobin-based oxygen carriers designed to help stabilize the patient and prevent tissue damage or organ dysfunction associated with oxygen deprivation. The company's oxygen carriers when intravenously administered, increase the oxygen-carrying capacity of the blood, enabling healthcare providers to treat patients and improve their quality of life.
Contact Information
Website
www.hbo2therapeutics.comCorporate Office
- 674 Souder Road
- Souderton, PA 18964
- United States
Corporate Office
- 674 Souder Road
- Souderton, PA 18964
- United States
HbO2 Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. IPO | 26-Apr-2022 | $30M | Cancelled | Generating Revenue | ||
| 3. Debt - PPP | 27-Apr-2020 | Completed | Generating Revenue | |||
| 2. Seed Round | 13-Apr-2015 | $2.75M | $5.5M | Completed | Generating Revenue | |
| 1. Seed Round | 13-Mar-2015 | $2.75M | $2.75M | Completed | Startup |
HbO2 Therapeutics Comparisons
Industry
Financing
Details
HbO2 Therapeutics Competitors (2)
One of HbO2 Therapeutics’s 2 competitors is Advanced Oxygen Therapy, a Private Debt Financed company based in Oceanside, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Advanced Oxygen Therapy | Private Debt Financed | Oceanside, CA | ||||
| Hamilton Medical | Corporation | Switzerland |
HbO2 Therapeutics Patents
HbO2 Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220354930-A1 | Hemoglobin substitute mixtures including reconstituted plasma and platelets and their manufacture and use | Pending | 02-Jul-2019 | ||
| AU-2020331892-A1 | Hemoglobin substitute mixtures including reconstituted plasma and platelets and their manufacture and use | Inactive | 02-Jul-2019 | ||
| CA-3143968-A1 | Hemoglobin substitute mixtures including reconstituted plasma and platelets and their manufacture and use | Pending | 02-Jul-2019 | ||
| US-20140227677-A1 | Perfusion of prospective donor hearts with polymerized hemoglobin | Inactive | 07-Feb-2013 | ||
| US-20200060260-A1 | Compositions and methods for organ preservation | Inactive | 12-Oct-2012 | A01N1/0226 |
HbO2 Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
HbO2 Therapeutics FAQs
-
When was HbO2 Therapeutics founded?
HbO2 Therapeutics was founded in 2014.
-
Where is HbO2 Therapeutics headquartered?
HbO2 Therapeutics is headquartered in Souderton, PA.
-
What is the size of HbO2 Therapeutics?
HbO2 Therapeutics has 8 total employees.
-
What industry is HbO2 Therapeutics in?
HbO2 Therapeutics’s primary industry is Medical Supplies.
-
Is HbO2 Therapeutics a private or public company?
HbO2 Therapeutics is a Private company.
-
What is HbO2 Therapeutics’s current revenue?
The current revenue for HbO2 Therapeutics is .
-
How much funding has HbO2 Therapeutics raised over time?
HbO2 Therapeutics has raised $5.5M.
-
Who are HbO2 Therapeutics’s competitors?
Advanced Oxygen Therapy and Hamilton Medical are competitors of HbO2 Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
